Cargando…
Identification of novel furo[2,3-d]pyrimidine based chalcones as potent anti-breast cancer agents: synthesis, in vitro and in vivo biological evaluation
Various substituted synthetic chalcones demonstrated potent anti-cancer activities. In the current study a series of novel furo[2,3-d]pyrimidine based chalcones were synthesized as potential anticancer agents. Among the different substituted derivatives, two of the halogen bearing chalcones, 5d and...
Autores principales: | Mansour, Mai A., Oraby, Mamdouh A., Muhammad, Zeinab A., Lasheen, Deena S., Gaber, Hatem M., Abouzid, Khaled A. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982411/ https://www.ncbi.nlm.nih.gov/pubmed/35424720 http://dx.doi.org/10.1039/d2ra00889k |
Ejemplares similares
-
Elaborating piperazinyl-furopyrimidine based scaffolds as phosphoinositol-3-kinase enzyme alpha (PI3Kα) inhibitors to combat pancreatic cancer
por: Mansour, Mai A., et al.
Publicado: (2020) -
Design, synthesis, and biological evaluation of new thieno[2,3-d] pyrimidine derivatives as targeted therapy for PI3K with molecular modelling study
por: Elmenier, Fatma M., et al.
Publicado: (2021) -
Discovery of Potent VEGFR-2 Inhibitors based on Furopyrimidine and Thienopyrimidne Scaffolds as Cancer Targeting Agents
por: Aziz, Marwa A., et al.
Publicado: (2016) -
Design and synthesis of phthalazine-based compounds as potent anticancer agents with potential antiangiogenic activity via VEGFR-2 inhibition
por: Elmeligie, Salwa, et al.
Publicado: (2019) -
Molecular design, synthesis and biological evaluation of novel 1,2,5-trisubstituted benzimidazole derivatives as cytotoxic agents endowed with ABCB1 inhibitory action to overcome multidrug resistance in cancer cells
por: Abdelhafiz, Abeer H. A., et al.
Publicado: (2022)